Genmab - Video abot the Lyra study
-
"Dr Habte Yimer speaks to ecancer at ASH 2018 about the Lyra study, a phase II study that uses daratumumab (dara) plus cyclophosphamide, bortezomib, and dexamethasone (CyBorD) to treat newly diagnosed and relapsed patients with multiple myeloma (MM)"
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind